DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2rwb9n/vital_signs_the) has announced the addition of the "Vital Signs - The Analyst's Perspective - November Issue" report to their offering.
This issue of Vital Signs, released on December 5, 2014, discusses LabCorp's acquisition of Covance, MedImmune's acquisition of Definiens, the Google X cancer and heart attack detector, and VWR's acquisition of two fluid handling components companies.
This research includes:
- LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World's Leading Healthcare Diagnostics Company
- AstraZeneca's MedImmune to Acquire Definiens for $150 Million
- Google X: One Small Step for Preventative Medicine, but One Giant Leap for Healthcare
- VWR Acquires 2 Fluid Handling Components Companies-Integra Companies, Inc. and STI Components, Inc.
For more information visit http://www.researchandmarkets.com/research/2rwb9n/vital_signs_the